摘要
目的：比较香港保健协会提供的复方丹参黄芪（ＳＭ＋ＲＡ）胶囊与广州白云山制药厂生产的复方丹参片（ＳＭ）治疗冠心病心绞痛的疗效。方法：稳定型心绞痛３０例（男性１５例，女性１５例；年龄６０±ｓ８ａ）采用复方ＳＭ＋ＲＡ胶囊２粒（含４０ｍｇ／粒）ｐｏ，ｔｉｄ，共４ｗｋ。另１１例稳定型心绞痛病人（男性８例，女性３例；年龄６３±８ａ）采用复方ＳＭ片，３片，ｐｏ，ｔｉｄ，共４ｗｋ。２组伴有高血压病人（前者１７例，后者４例）继续采用复方降压片，复方罗布麻叶片或卡托普利。结果：心绞痛症状疗效与静息心电图疗效：前者依次为９７％与６４％；后者依次为９１％与３６％，但组间比较，Ｐ＞０．０５。结论：复方ＳＭ＋ＲＡ胶囊治疗冠心病心绞痛疗效好，不良反应少。
AIM :To compare the capsule of Salvia miltiorrhiza-Astragalus compound (SM+RA Co)(Hong Kong Association for Health Care Ltd) and tablet of Salvia miltiorriza Co(SM Co) on coronary disease. METHODS: Thirty patients(M 15, F 15;age 60±s 8 a)with angina pectoris were given SM+RA Co capsules, 2 Cap (40 mg/Cap),tid for 4 Wk. Another 11 patients(M8, F 3;age 63±8a)were given SM Co tablets, 3 Tab,tid for 4 wk. Patients with hypertension (SM+RA Co group, 17 patients,SM Co group, 4 patients) were given captopril or Luo-bu-ma Co continually. RESULTS:SM+RA Co and SM Co relieve symtom of angina pectoris were 97%and 91%(P>0.05),and improve ECG were 64% and 36(P< 0.05) respectively.CONCLUSION:SM+RA Co is superior to SM Co in treating coronary disease.
出处
《新药与临床》
CSCD
北大核心
1995年第6期332-335,共4页
关键词
丹参
黄芪
心绞痛
中草药
心电描记术
Salvia miltiorriza
Radix astragali
angina pectoris
Chinese herbal drugs
electrocardiography
